RC
RVMDW icon

Rangeley Capital’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Rangeley Capital’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.68M Buy
+25,000
New +$135K 4.28% 2

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Rangeley Capital's RVMDW Position: Q2 2026 in Review

Rangeley Capital opened a new position in Revolution Medicines Inc Warrant (RVMDW) in Q2 2026: 25,000 shares worth $4.68M. The stake represents 4.28% of the portfolio and ranks #2 among its holdings.

22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

  • Rangeley Capital held 25,000 shares of Revolution Medicines Inc Warrant worth $4.68M as of Q2 2026.
  • Revolution Medicines Inc Warrant was a new Rangeley Capital position in Q2 2026.
  • Revolution Medicines Inc Warrant made up 4.28% of Rangeley Capital's portfolio in Q2 2026, its #2 holding.
  • 22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.